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Background:  Polychlorinated  biphenyls  (PCBs)  are  chemicals  which  were  used  for  industrial  purposes  and
are known  to  induce  various  adverse  health  effects.  They  are  also  known  to  be neurotoxic  and  numerous
targets  within  the  central  nervous  system  have  been  identiﬁed  in  previous  studies.  Speciﬁcally,  the  neu-
rotransmitters  dopamine  (DA)  and  norepinephrine  (NE)  are  inﬂuenced  by PCBs  as  indicated  in  studies
involving  animals.  However,  limited  evidence  has been  published  documenting  PCB  induced  changes  in
the neurotransmitter  system  in  humans.
Objective:  In  the  present  study,  we  examined  the association  between  a higher  PCB  body  burden  following
occupational  exposure  and  possible  changes  in human  neurotransmitter  metabolites.
Methods: Within  a medical  surveillance  programme  called  HELPcB  (Health  Effects  in High-Level  Exposure
to PCB)  that  monitors  adverse  health  effects  of occupational  PCB  exposure,  urine  samples  were  obtained
(nT1 = 166; nT2 =  177  and  nT3 =  141).  The  urinary  concentrations  of  the  metabolites  homovanillic  acid  (HVA;
for  DA)  and  vanillylmandelic  acid  (VMA;  for NE)  were  analyzed.  Blood  samples  were  obtained  by  vena
puncture  in  order  to determine  the  internal  exposure  to PCBs  with  human  biomonitoring.
Results: A  cross-sectional  analysis  indicated  a signiﬁcant  negative  effect  of PCB  exposure  on  HVA  and
VMA.  Longitudinally,  an  initially  higher  exposure  to higher  chlorinated  PCBs  was  followed  by constant
reduced  HVA  level  over  three  consecutive  years.  Exploratory  analyses  show  different  long-term  effects
for  different  PCBs  according  to their  chlorination  degree.  A  higher  exposure  with  lower  chlorinated  PCBs
leads  to an  increase  of VMA  and  HVA.  Conversely,  a higher  exposure  to all PCBs  results  in a reduction  of
HVA.
Conclusion:  This study,  to our  knowledge,  is the  ﬁrst  to  document  changes  in  neurotransmitter  metabolites
after  occupational  PCB  exposure  in humans.  This  ﬁnding  advances  evidence  obtained  from  past  research,
and  identiﬁes  one  potential  pathomechanism  in  the central  dopaminergic  system  of  humans.
© 2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ntroduction
Polychlorinated biphenyls (PCBs) are hazardous chemicals. They
re a group of synthetic biphenyl rings containing one to ten
hlorine substitutions (Evangelista de Duffard and Duffard, 1996).
CBs have been produced commercially since the 1920s and have
een widely used in the electrical and chemical industries. Due
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niversity, Pauwelsstraße 30, D-52074 Aachen, Germany. Tel.: +49 241 80 8888;
ax: +49 241 80 82587.
E-mail address: franziska.putschoegl@rwth-aachen.de (F.M. Putschögl).
ttp://dx.doi.org/10.1016/j.ijheh.2015.03.009
438-4639/© 2015 The Authors. Published by Elsevier GmbH. This is an open acces
y-nc-nd/4.0/).to their chemical properties, they are extremely persistent and
show bioaccumulation in food chains. Previous studies have docu-
mented elevated levels of PCBs in higher trophic organisms, with
particularly high concentrations found in adipose tissue (Faroon
et al., 2003; Stroh, 2008). Despite their ban or restriction in many
countries (Schettgen et al., 2012), the general population continues
to be exposed to PCBs environmentally (e.g., via air, drinking-
water or food). Furthermore, occupational exposure can occur at a
much higher grade during repair, maintenance, and disposal of PCB
transformers or older electrical instruments (Faroon et al., 2003;
Wolff, 1985). Human exposure to chemicals makes it imperative to
address possible negative health effects in individuals who exhibit
higher internal PCB levels due to occupational exposure.
s article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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PCBs have different harmful biological effects and are consid-
red to be one of the most concerning environmental contaminants
McFarland and Clarke, 1989). For example, it has been reported
hat PCBs interfere in complex ways with hormone systems such as
he thyroid axis (Leijs et al., 2012; Persky et al., 2012) or the repro-
uctive system (Goncharov et al., 2009), and they are also known
o be potent immunotoxicants (Crinnion, 2011).
Additionally, the neurotoxic effects of PCBs have been exten-
ively investigated. Many studies have focused on toxic effects in
eonates and young children who were exposed to PCBs in utero or
ostnatally via ingestion of PCB contaminated breast milk (Faroon
t al., 2000). Other researchers have reported long lasting effects
f PCBs on the developing brain and alterations in cognitive func-
ions (Evangelista de Duffard and Duffard, 1996; Faroon et al.,
000). Negative effects to the central nervous system (CNS) in adult
umans, such as a decrease of performance in memory, learning,
xecutive functions or attention, have been reported after both
nvironmental and occupational exposure to PCBs (Faroon et al.,
003; Fitzgerald et al., 2008; Haase et al., 2009; Kodavanti, 2005;
eper et al., 2005).
Several studies have attempted to elucidate underlying path-
mechanisms of the reported neurotoxic effects after PCB exposure.
umerous targets within the CNS have been described in animal
tudies so far. Among these are alterations of the intracellular cal-
ium (Ca2+) level (Tilson and Kodavanti, 1997), disruption of signal
ransduction pathways (Kodavanti and Tilson, 2000), as well as
hanges in synaptic plasticity and decreased cell viability (Fonnum
nd Mariussen, 2009). In past research, an association between
hanges in the neurotransmitter system (i.e., dopamine system)
nd cognitive dysfunction has been described (Cropley et al., 2006).
he focus of the present study lies on changes in the neurotrans-
itter system, which is one of the most studied PCB-related targets
n animals.
Studies on developmental exposure using animals have shown
hat changes in dopamine (DA) concentrations in the brain are
ependent on the neurotransmitter system and on the congeners
nvolved. Coplanar PCBs are supposed to consistently increase DA
oncentration in the medial prefrontal cortex after developmental
xposure (Seegal et al., 2005), whereas non-coplanar PCBs induce
ecreases in DA concentrations in the striatum and other brain
egions (Seegal et al., 1990). Non-developmental studies, which are
he basis for the present study, indicate that transport mechanisms
f the neurotransmitters (e.g., DA) seem to be particularly sensitive
o PCBs. Speciﬁcally, PCBs have been found to induce the inhibition
f the vesicular monoamine transporter (VMAT) and a decreased
xpression of the DA transporter (DAT) (Bemis and Seegal, 2004;
ariussen et al., 1999; Richardson and Miller, 2004). Both mecha-
isms may  be a reason for changes in the DA function. Preliminary
ndings have also been reported in studies with human subjects.
eegal et al. (2010) used a -CIT SPECT imaging technique to inves-
igate the effect of PCBs on striatal DAT density. They found a
educed DAT density in occupationally exposed women (Seegal
t al., 2010) consistent with the described changes in the DAT in
nimal studies. However, a relation between PCB exposure and
AT density was not signiﬁcant for men  after controlling for rele-
ant confounding factors. Taken together these ﬁndings sustain the
lausibility of PCB induced DA decrease. However, further research
ith human subjects is needed. The most consistent ﬁnding regard-
ng actual changes of neurotransmitter levels in relation to PCBs
as a DA decrease in the adult nervous system in animals (Faroon
t al., 2000; Seegal et al., 1994, 1988, 1986).
In addition to DA, past research has analyzed norepinephrine
NE) as a relevant neurotransmitter that could be affected by PCB
xposure. A decreased concentration of NE in the brain after PCB
xposure has been described in studies involving animals (Seegal
t al., 1985; Tilson and Kodavanti, 1997). PCB induced effects onand Environmental Health 218 (2015) 452–460 453
NE in studies with humans is needed. Therefore, the present study
includes NE as a potential effect variable in humans.
In sum, this study aims at providing further evidence in the
reported association between PCBs and changes in DA and NE by
studying the PCB effect in occupationally exposed workers. Because
changes in the neurotransmitter system are difﬁcult to assess,
previous studies have focussed on possible alterations in periph-
eral neurotransmitter metabolites due to PCB exposure, especially
because peripheral metabolites of neurotransmitters are easier to
obtain (Seegal et al., 1988). The present study examines the effects
of an occupational PCB exposure on urinary metabolites of rele-
vant neurotransmitters. Homovanillic acid (HVA), being the major
DA metabolite in urine, is thought to reﬂect changes in the central
dopaminergic system in human patients (Amin et al., 1992). For NE,
we use vanillylmandelic acid (VMA) as its metabolite.
We  hypothesized that high levels of PCBs result in reduced con-
centrations of HVA and VMA  in urine from humans exposed to high
levels of PCBs by working at contaminated sites.
In addition, because past research reported acute as well as
chronic effects in animals (Seegal et al., 1994, 1986), we  also want
to address longitudinal effects, and by considering the effect of the
initial PCB exposure level, we  expect to ﬁnd, in line with Seegal
et al. (1994), a reduced level of neurotransmitter metabolites over
time.
Moreover, Richardson and Miller (2004) found different time-
related effects of PCBs on neurotransmitter metabolites, such as
HVA, depending on the degree of chlorination. The authors reported
a decrease in HVA levels in mice after exposure to PCB mixtures,
namely Aroclor 1260 (mainly composed of high-chlorinated PCBs)
and Aroclor 1016 (which contains mainly low-chlorinated con-
geners). Exposure to Aroclor 1260 lead to a stronger decrease
in HVA levels than exposure to Aroclor 1016 within a period of
one week after exposure. However, 14 days after exposure, there
were no signiﬁcant differences in HVA levels for either experimen-
tal group when compared to the non-exposed control group. To
account for potential mixed exposure effects in our study, we con-
duct explorative longitudinal analyses by focusing on the different
effects of several PCB types according to their degree of chlorina-
tion.
Methods
Study design
In 2010, high internal exposures to PCBs were discovered in
workers of a transformer recycling company in Germany. Human
biomonitoring revealed high body burden also in workers in sur-
rounding locations of this plant, in residents in close vicinity to
this plant, and in relatives of the workers (Bruckmann et al., 2011;
Kraus et al., 2012). As a consequence, a medical surveillance pro-
gramme  named HELPcB (Health Effects in High-Level Exposure
to PCB) was  initiated in order to monitor possible adverse health
effects (Kraus et al., 2012). As part of this programme, the present
study focuses on possible alterations in urinary neurotransmitter
metabolites HVA and VMA. Participation was voluntary and all par-
ticipants gave informed consent. The study was approved by the
local ethics committee of the university (EK 176/11).
Study population
One hundred and ninety-one urinary samples were collected at
time 1 (T1), 209 at time 2 (T2), and 152 at time 3 (T3). Thereof,
all samples with urinary creatinine (Crea) concentrations outside a
physiological range of 0.3–3 g/l were excluded according to inter-
national standard procedures as outlined by the World Health
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Table  1
Information about programme participants.
T1 T2 T3
Collected urinary samples 192 209 152
Excluded due to values outside physiological range:
Urinary creatininea 18 18 8
HVA/Creab 7 9 3
VMA/Creac 1 5 0
Included urinary samples 166 177 141
Participants information
Sex m = 149 (90.3%); w = 16 (9.7%) m = 153 (86.4%); w = 24 (13.6%) m = 119 (84.5%); w = 22 (15.5%)
Age  M = 46.6; SD = 12.0; range: 16–72y M = 47.6; SD = 12.6; range: 16–73y M = 47.8; SD = 11.8; range: 26–73y
Note: T1, time one; T2, time two; T3, time three; HVA/Crea, ratio of homovanillic acid to creatinine [mol/g Crea]; VMA/Crea, ratio of vanillylmandelic acid to creatinine
[mol/g Crea]; m,  men; w,  women; M,  mean; SD, standard deviation; y, years.
a Physiological range of 0.3–3 g/l.
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rganization (Hoet, 1996). Moreover, to the best of our knowl-
dge, the literature provides limited evidence towards a potential
ealth effect of kidney function in humans (e.g., Chen et al., 2006).
owever, at study onset there was no association between PCB
xposure and creatinine. In addition, as outliers reduce the informa-
ive value of correlations, especially in case of a skewed distribution
Wirtz and Nachtigall, 2006), all samples with urinary HVA con-
entrations outside a physiological range of <42 mol/g Crea and
ith urinary VMA  concentrations outside a physiological range of
30 mol/g Crea, as given by internal laboratory reference values,
ere excluded. Table 1 provides information about the included
amples of participants. Following this procedure, the ﬁnal sample
onsisted of 166 participants at T1, 177 at T2 and 141 at T3.
To screen for a potential systematic effect of the excluded uri-
ary samples a t-test was  conducted. No signiﬁcant differences
ere obtained between those participants included in the ﬁnal
ample compared to the total number of participants (N = 300)
ecruited to the HELPcB programme in terms of sex, age, height,
eight, employment status, PCB plasma concentrations or urinary
reatinine concentrations.
The participants in our study were exposed to PCBs over a rel-
tively long period of time (M = 67.03 weeks; SD = 82.97 weeks;
ange = .6–337.7 weeks). For a complete information about internal
CB exposure see the supplemental material (Table S1).
lasma PCB analyses
Blood samples of participants were obtained by vena punc-
ure and current PCB plasma levels were analyzed in order to
etermine the internal exposure to PCBs using a slightly modi-
ed method approved by the German Research Association (DFG)
Schettgen et al., 2012, 2011; Schulte et al., 1990). Two mL  of
lasma were homogenized using formic acid. The PCBs were
hen extracted with n-hexane and clean-up was performed on a
ilica gel-column (Schettgen et al., 2012, 2011). Gas chromatogra-
hy/electron ionization-mass spectroscopy (GC/EI-MS) in selected
on monitoring mode (SIM) was used for quantiﬁcation, and the
imit of detection was determined to be 0.01 g/L (Schettgen et al.,
012, 2011). For more detailed information see Schettgen et al.
2012, 2011). Because the adjustment of PCBs with serum lipid can
ias the results (Schisterman et al., 2005), we followed a proce-
ure explained by Bernert et al. (2007) using total lipid values as a
ontrol variable.
Because the toxic equivalency factors (TEFs) for each dioxin-
ike PCB congener included in this study are identical, with a value
f 0.0003, the TEFs were not included in the analysis because the
ongeners do not differ in their relative potency (Van den Berg et al.,
006).Assay of urinary HVA and VMA
Random urine samples were obtained from participants
between 09.00 a.m. and 11.00 a.m. Urine concentrations of crea-
tinine were analyzed by Jaffe colour reaction and HVA and VMA
concentrations were analyzed by high performance liquid chro-
matography (HPLC; Gressner and Arndt, 2013; Renz, 2014). In order
to standardize the measurement of the metabolites, the values are
expressed as ratio of HVA to creatinine (HVA/Crea) in mol/g Crea,
and ratio of VMA  to creatinine (VMA/Crea) in mol/g Crea (Amin
et al., 1992).
Statistical analyses
Statistical analyses were performed using SPSS version 21 (IBM,
2012) and proceeded in three stages. First, a partial correlation anal-
ysis controlling for age and serum total lipids was conducted in
order to determine the association between all analyzed PCBs and
the metabolites at each cross-section. Therefore, we performed the
correlation analysis with the metabolites HVA/Crea and VMA/Crea
and the PCB congeners 28, 52, 101, 138, 153, 180, 105, 114, 118,
123, 156, 157, 167, and 189. To generalize the analysis, the differ-
ent congeners were also grouped into sum-variables according to
their degree of chlorination: lower chlorinated PCBs (LPCBs) includ-
ing the congeners 28, 52 and 101; higher chlorinated PCBs (HPCBs)
including the congeners 138, 153 and 180 and dioxin-like PCBs
(dlPCBs) including the congeners 105, 114, 118, 123, 156, 157, 167,
and 189.
In the second step, an analysis of the longitudinal effects of
the grouped PCBs with the major metabolites was  performed
with repeated measures ANCOVA. In order to compare higher
PCB exposed participants with normal exposed participants, the
three continuous PCB sum-variables LPCBs, HPCBs and dlPCBs were
transformed into three dichotomous variables by splitting on the
95th percentile of a reference sample of the general population in
Germany with no additional occupational PCB exposure. PCB val-
ues were coded as “1” (=higher-PCB-burden) when participants had
PCB plasma levels higher than the 95th percentile of the reference
sample. Values equal or lower were coded with “0” (=normal-PCB-
burden). The PCB body burden of the normal exposed participants
and the PCB body burden of the reference sample are equivalent
(Schettgen et al., 2011). The dichotomized initial PCB burden from
T1 was  included as predictor and the respective metabolite of each
cross-section as the outcome variable; age was  considered in the
analyses as a control variable. Levene’s test was  carried out in order
to test the homogeneity of variances. All variances of the different
groups were homogeneous, thus we  could perform the ANCOVA
(Wirtz and Nachtigall, 2006).
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Table  2
Partial correlations between all PCBs and the metabolites of dopamine (HVA) and norepinephrine (VMA); controlling for age and total serum lipid (Bernert et al., 2007).
HVA/Crea T1a VMA/Crea T1a HVA/Crea T2b VMA/Crea T2b HVA/Crea T3c VMA/Crea T3c
PCB 28 −.15† −.08 −.11 −.10 −.14 −.04
PCB  52 −.21** −.08 .04 −.03 −.08 −.12
PCB  101 −.20* −.04 .06 −.04 −.10 −.10
PCB  138 −.23** −.04 −.02 −.20** −.10 −.14†
PCB 153 −.23** −.05 −.01 −.20** −.09 −.14†
PCB 180 −.23** −.05 .00 −.19* −.08 −.15†
PCB 105 −.18* −.03 −.05 −.18* −.14 −.09
PCB  114 −.23** −.06 −.06 −.16* −.13 −.14
PCB  118 −.19* −.02 −.05 −.18* −.14 −.10
PCB  123 −.18* −.04 −.06 −.15† −.14 −.07
PCB  156 −.24** −.03 −.02 −.15* −.09 −.16†
PCB 157 −.22** −.02 −.02 −.13† −.10 −.17*
PCB 167 −.23** −.03 −.01 −.17* −.12 −.14†
PCB 189 −.24** −.05 −.01 −.14† −.09 −.17*
LPCBs −.17* −.08 −.10 −.10 −.14 −.04
HPCBs −.25** −.02 −.01 −.20** −.09 −.14†
dlPCBs −.23** −.01 −.04 −.18* −.14 −.11
PCBs, polychlorinated biphenyls; LPCBs, lower chlorinated PCBs; HPCBs, higher chlorinated PCBs; dlPCBs, dioxin-like PCBs; HVA/Crea, ratio of homovanillic acid to creatinine
[mol/g  Crea]; VMA/Crea, ratio of vanillylmandelic acid to creatinine [mol/g Crea]; T1, time one; T2, time two; T3, time three.
a n (T1) = 166.
b n (T2) = 177.
c (T3) = 141.
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In the third step, an exploratory analysis of the longitudi-
al effects of the different PCB types with the major metabolites
as performed with repeated measures ANCOVA. We  used the
ichotomized initial PCB burden from T1 to categorize our sam-
le in relation to the chlorination degree of the PCBs. Altogether,
ve groups were created: participants with all PCBs under the 95th
ercentile (1), only LPCBs above the 95th percentile (2), only HPCBs
bove the 95th percentile (3), LPCBs and dlPCBs above the 95th
ercentile (4) and ﬁnally participants with all PCBs above the 95th
ercentile (5). No participant showed a higher exposure only in
lPCBs or only in both LPCBs and HPCBs. Group number 3 con-
isted of two participants and was therefore excluded from further
nalysis. Because it is possible that individuals may  be classiﬁed in
nother group in the course of the three years, we used the ini-
ial PCB burden from T1 as predictor for a better interpretation
nd group comparison. The respective metabolite of each cross-
ection was the outcome variable and age was included as control
ariable. Box’s M test was conducted in order to test the homogene-
ty of covariances. All variances of HVA/Crea were homogeneous
or the different groups, but related to VMA/Crea the Box’s M test
howed signiﬁcant differences in group variances. Therefore the
esults must be interpreted carefully.
For the second and third step, we included only those partici-
ants that took part in all three cross-sections (71 participants for
he analyses with HVA/Crea and 70 participants for the analyses
ith VMA/Crea). The level of signiﬁcance was p < .05.
esults
ross-sectional effects
Table 2 presents the results of the partial correlation between all
CB congeners and the metabolites HVA/Crea and VMA/Crea from
he corresponding cross-section, controlling for age and serum total
ipids.
In accordance with the literature, for T1 a signiﬁcant negative
orrelation between HVA/Crea and PCBs could be found for all PCB
ongeners as well as the sum variables, except PCB 28. No signif-
cant correlation between PCBs and VMA/Crea could be found for
1.At T2, no signiﬁcant correlations between any PCB congener and
HVA/Crea were present. However, the sum-variable HPCBs and its
congeners as well as the sum-variable dlPCBs and its congeners,
except for congener 123, 157 and 189, were signiﬁcantly nega-
tively correlated with VMA/Crea at T2. No signiﬁcant effects could
be found for LPCBs on either congener.
For T3, no signiﬁcant correlations between any PCB congener,
the sum variables, and HVA/Crea could be detected. For VMA/Crea
only small correlations with the congeners 157 and 189 were
detected. No signiﬁcant correlations were found for all other PCBs.
Table 2 contains detailed information.
Longitudinal effects
Fig. 1 shows the results of a repeated measures ANCOVA
for HVA/Crea, controlling for age. Results indicate a signiﬁ-
cant between-subjects effect for the sum variable of HPCBs,
with higher exposed participants having a reduced metabolite
level (Fig. 1b). A non-signiﬁcant between-subjects effect was
found for dlPCBs (Fig. 1c), with a trend in the same direction.
No between-subjects-effect was  found for LPCBs. No signiﬁ-
cant within-subjects effect was  found; neither for LPCBs and
HPCBs nor for dlPCBs. The results show no signiﬁcant interac-
tions between normal and higher exposed participants. In the
group of the higher exposed participants to LPCBs, HPCBs and
dlPCBs, we  were able to show a signiﬁcant increase of HVA/Crea
between T1 and T2 and a signiﬁcant decrease between T2 and
T3 (Table 3). Further, a signiﬁcant decrease in HVA/Crea from
T1 to T3 was seen in the group of the normal exposed partic-
ipants to LPCBs and HPCBs. For more detailed information see
Table 3.
Fig. 2 shows the repeated measures ANCOVA controlling
for age for VMA/Crea. Overall, neither signiﬁcant between-
subjects effects, nor within-subjects effects or interactions were
detected. For higher exposed participants to HPCBs and dlPCBs,
the results show a signiﬁcant decrease in VMA/Crea between
T2 and T3 (Table 3). No signiﬁcant changes in VMA/Crea could
be found for higher exposed participants to LPCBs and dlPCBs
and for normal exposed participants. For further information see
Table 3.
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Fig. 1. Repeated measures ANCOVA controlling for age; effect of PCBs on the transmitter metabolite homovanillic acid. PCBs, polychlorinated biphenyls; h LPCBs, high
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mol/g Crea]; T1, time one; T2, time two; T3, time three.
xplorative longitudinal effects
Results of a repeated measures ANCOVA for HVA/Crea, con-
rolling for age, are illustrated in Fig. 3. The ﬁndings indicate
 signiﬁcant main effect between the different types of PCBs
F(3,60) = 3.1; p = .03; 2 = .14). The pairwise comparisons give more
etailed information about these differences over the three years.
articipants with an elevated exposure only to LPCBs show a higher
evel in HVA/Crea (M = 20.1; SE = 1.0) than participants with eleva-
ion in all PCBs (M = 16.1; SD = .9; mean difference = 4.0; p = .004).
ig. 4 shows the respective results for VMA/Crea. For VMA/Crea,
he main effect was solely a trend for the several types of PCBs
F(3,65) = 2.6; p = .06; 2 = .11). However, the pairwise comparison
hows a signiﬁcant higher VMA/Crea for those participants with
able 3
xplorative results from the repeated measurement ANCOVA controlling for age: longitu
HVA/Crea [mol/g Crea] 
LPCBs HPCBs dlPCBs 
h LPCBs n LPCBs h HPCBs n HPCBs h dlPCBs n dlPCBs
N 49 22 24 47 37 34 
MT1 17.51 20.14 15.57 19.69 16.94 19.87 
MT2 19.36 19.10 18.53 19.65 19.04 19.30 
MT3 17.14 17.42 15.94 17.87 16.41 18.08 
MDiff
I–II −1.85* 1.04 −2.97** 0.04 −2.10* .57 
I–III  0.37 2.72* −0.37 1.81* 0.53 1.79†
II–III  2.21** 1.68 2.59* 1.78* 2.63** 1.22 
CBs, polychlorinated Biphenyls; LPCBs, lower chlorinated PCBs; HPCBs, higher chlorinate
 LPCBs, normal exposure to lower chlorinated PCBs; h HPCBs, high exposure to higher chl
xposure to dioxin-like PCBs; n dlPCBs, normal exposure to dioxin-like PCBs; M,  mean; M
mol/g  Crea]; VMA/Crea, ratio of vanillylmandelic acid to creatinine [mol/g Crea]; T1, 
* p < .05.
** p < .01.
† p < .10.s; h HPCBs, high exposure to higher chlorinated PCBs; n HPCBs, normal exposure
al exposure to dioxin-like PCBs; HVA/Crea, ratio of homovanillic acid to creatinine
a higher burden only in LPCBs (M = 15.9; SE = 1.0) in comparison
to participants with an elevation in all PCBs (M = 13.5; SE = 1.0;
mean difference = 2.4; p = .02) and with participants with no ele-
vated PCBs (M = 13.7; SE = 1.0; mean difference = 2.2; p = .03). All
means are listed in Table 4.
Discussion
The present study investigated changes in the human neu-
rotransmitter system via transmitter-metabolites of DA and NE
as possible neurotoxic effects after occupational PCB exposure.
Cross-sectionally, we found a decrease of metabolite levels with
increasing PCB exposure. Longitudinally, individuals with ini-
tially elevated HPCB exposure also showed reduced HVA levels in
dinal effects of HVA and VMA  within the higher and normal exposed participants.
VMA/Crea [mol/g Crea]
LPCBs HPCBs dlPCBs
 h LPCBs n LPCBs h HPCBs n HPCBs h dlPCBs n dlPCBs
48 22 23 47 36 34
14.81 14.75 13.48 15.42 14.65 15.07
14.66 15.20 14.71 14.88 15.16 14.64
13.96 14.24 12.74 14.67 13.63 14.51
0.15 −0.45 −1.24 0.54 −0.52 0.43
0.85† 0.51 0.74 0.75 1.02† 0.56
0.70 0.96 1.98* 0.21 1.53* 0.13
d PCBs; dlPCBs, dioxin-like PCBs; h LPCBs, high exposure to lower chlorinated PCBs;
orinated PCBs; n HPCBs, normal exposure to higher chlorinated PCBs; h dlPCBs, high
Diff , difference of mean values; HVA/Crea, ratio of homovanillic acid to creatinine
time one; T2, time two; T3, time three.
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Fig. 2. Repeated measures ANCOVA controlling for age; effect of PCBs on the transmitter metabolite vanillylmandelic acid. PCBs, polychlorinated biphenyls; h LPCBs, high
exposure to lower chlorinated PCBs; n LPCBs, normal exposure to lower chlorinated PCBs; h HPCBs, high exposure to higher chlorinated PCBs; n HPCBs, normal exposure to
h mal e
[
c
i
e
b
T
I
i
V
b
s
D
p
h
d
e
p
s
t
T
E
N
higher  chlorinated PCBs; h dlPCBs, high exposure to dioxin-like PCBs; n dlPCBs, nor
mol/g  Crea]; T1, time one; T2, time two; T3, time three.
omparison to normal burdened participants over time. Interest-
ngly, our exploratory analyses revealed potential mixed exposure
ffects.
The cross-sectional analysis revealed a negative correlation
etween all analyzed PCB congeners and HVA/Crea only for T1.
his partially supports our hypothesis of a negative association.
n addition to effects on HVA/Crea, we were able to show an
nverse association between both HPCB and dlPCB body burden and
MA/Crea at T2 and smaller effects at T3. No signiﬁcant correlation
etween PCBs and VMA/Crea could be detected for T1. Previous
tudies from Seegal et al. (1988, 1985) describe a decrease of the
A metabolite HVA after PCB exposure. Numerous studies have
rovided information about PCB-related effects on central DA and
ave consistently stated that PCB exposure can induce a central
ecrease in DA in animals (Richardson and Miller, 2004; Seegal
t al., 1994). Further, results of animal studies indicated that trans-
ort mechanisms of the neurotransmitters seem to be particularly
ensitive to PCBs, e.g., via inhibition of the vesicular monoamine
ransporter (VMAT), and a decreased expression of the DAT (Bemis
able 4
xplorative results from the repeated measurement ANCOVA controlling for age: mean o
HVA/Crea [mol/g Crea] 
All
PCBs < 95th
PC
Only
LPCBs > 95th
PC
LPCBs and
dlPCBs > 95th
PC
All
PCBs > 95th
PC
n 16 16 11 22 
MT1 19.4 20.3 19.8 14.7 
MT2 18.6 20.9 18.6 17.5 
MT3 17.7 18.9 17.1 16.0 
ote: PCBs, polychlorinated biphenyls; LPCBs, lower chlorinated PCBs; HPCBs, higher chlo
omovanillic acid to creatinine [mol/g Crea]; VMA/Crea, ratio of vanillylmandelic acid txposure to dioxin-like PCBs; VMA/Crea, ratio of vanillylmandelic acid to creatinine
and Seegal, 2004; Mariussen et al., 1999; Richardson and Miller,
2004; Seegal et al., 2010). There are few ﬁndings in humans sup-
porting these pathomechanisms. In one such study, Seegal et al.
(2010) reported a reduced DAT density in women exposed to PCBs
occupationally. Taken together, these pathomechanisms sustain
the plausibility of PCB induced DA decrease. In our study we were
also able to ﬁnd the signiﬁcant effects in a predominantly male
sample.
For VMA/Crea we found no cross-sectional association with
LPCBs. However, we found signiﬁcant negative correlations with
HPCBs, dlPCBs and the corresponding congeners for VMA/Crea, a
ﬁnding which is in accordance with previous research on NE (Seegal
et al., 1985; Tilson and Kodavanti, 1997).
Overall, we found weaker associations for LPCBs, a ﬁnding which
might be related to their degree of chlorination. An animal study
from Richardson and Miller (2004) shows a stronger decrease of
the HVA level following exposure to Aroclor 1260 (consisting of
more HPCBs) than following exposure to Aroclor 1016 (consisting
of more LPCBs) in mice.
f HVA and VMA for each exposure group.
VMA/Crea [mol/g Crea]
All
PCBs < 95th
PC
Only
LPCBs > 95th
PC
LPCBs and
dlPCBs > 95th
PC
All
PCBs > 95th
PC
17 19 12 22
13.7 16.2 15.5 13.7
14.1 15.5 14.5 14.1
13.4 16.0 14.8 12.8
rinated PCBs; dlPCBs, dioxin-like PCBs; M,  mean; PC, percentile; HVA/Crea, ratio of
o creatinine [mol/g Crea]; T1, time one; T2, time two; T3, time three.
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Fig. 3. Results of the ANCOVA with repeated measure of homovanillic acid (HVA)
in  relation to initial PCB burden; over a period of three years. The group with only
higher HPCB burden consists of two  participants and therefore was  excluded from
this  analysis. The groups only with elevated dlPCBs and with both elevated LPCBs
and HPCBs do not exist (HVA/Crea, ratio of homovanillic acid to creatinine [mol/g
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Longitudinal effects were examined in a subgroup of the sample
hat provided urinary and blood samples at all three measure-
ent time points: in accordance with previous research, the group
ith the higher initial PCB burden generally shows a lower level
f HVA/Crea. The permanent reduction of the HVA level during
he entire measurement period after high initial HPCB exposure
ndicates a chronic effect of these congeners, most likely due to
heir high persistence. Long lasting decreases in the central DA con-
entration have been previously reported in experimental animal
tudies (Seegal et al., 1994).
Overall, the result from the longitudinal analyses conﬁrms past
esearch (Seegal et al., 1986) on an impeding effect of PCBs on the
A neurotransmitter system. The group with a normal initial PCB
urden shows an overall decrease over time. Within the higher bur-
ened group an increase of HVA/Crea from T1 to T2 is followed by
 decrease between T2 and T3. For HVA, the opposite pattern can
e found in the literature. Richardson and Miller (2004) described
 decrease in HVA followed by an increase after exposure to PCB
ixtures. However, Seegal et al. (1988, 1985) have reported that
xposure to PCB mixtures results in a prolonged elevation in urinary
VA in the adult rat.
We could not detect differences between groups with normal
nd higher exposure to PCBs and VMA/Crea. We  found a VMA/Crea
ig. 4. Results of the ANCOVA with repeated measure of vanillylmandelic acid
VMA) in relation to initial PCB-burden; over a period of three years. The group with
nly higher HPCB-burden consists of two participants and therefore was excluded
rom this analysis. The groups only with elevated dlPCB and with both elevated
PCB and HPCB do not exist (VMA/Crea, ratio of vanillylmandelic acid to creatinine
mol/g Crea]; T1, cross section one; T2, cross section two; T3, cross section three).and Environmental Health 218 (2015) 452–460
decrease between T2 and T3 only in participants with a higher
burden in HPCBs and dlPCBs. To the best of our knowledge, no
longitudinal study for VMA  exists in the literature.
In the third part of our study, we  focused on potential mixed
exposure effects. We  classiﬁed the participants into ﬁve groups
according to their exposure pattern and found distinct effects on the
neurotransmitter system. The group which had an elevated level
only for LPCBs had in fact a higher level in HVA/Crea and VMA/Crea
than the reference group with no elevated PCB burden or the group
with an elevation in all types of PCBs. Past research gave ﬁrst hints
that the effect of PCBs is dependent on the degree of chlorina-
tion (Richardson and Miller, 2004). However, the research always
relied on PCB mixtures (since A1260 and A1016 were compared)
where only the relation of higher and lower chlorinated PCBs var-
ied. Our study also provides ﬁrst insight into the differential effects
resulting from exposure to PCB congeners with high versus low
chlorination.
To the best of our knowledge, this is the ﬁrst study to exam-
ine the effect of PCB exposure on this NE metabolite in humans.
In addition, we were able to monitor annually the adverse health
effects following occupational exposure to PCBs within the medi-
cal surveillance programme HELPcB. However, this study is limited
in detecting small effects due to its small number of individuals
examined, the studied sample has been highly exposed to PCBs for
a long period of time compared to the general population.
Although we  were able to show signiﬁcant association between
PCBs and urinary neurotransmitter metabolites, this measurement
can also be confounded and does not reﬂect the total central neu-
rotransmitter system. For HVA measurement, confounding factors
such as dietary constitution – for instance the consumption of
foods with high monoamine content (e.g., cheese, orange juice or
bananas) as well as individual variability – can compromise the
usefulness of the analyses (Amin et al., 1992). Additionally, only
12% of peripheral HVA derive from the brain and thus map  out cen-
tral alterations in the neurotransmitter DA (Eisenhofer et al., 2004).
Nevertheless, Amin et al. (1992) state that “despite its severe lim-
itations, the measurement of HVA in body ﬂuids is [. . .]  the most
direct method to assess the changing activity of central DA neu-
rons” (p. 139). For VMA, the variability in peripheral body ﬂuid
concentrations is also not only due to centrally alternated neu-
rotransmitters but mainly due to the degree of hepatic function
(Goldstein et al., 2003). The metabolism of NE in total is very com-
plex and the production of VMA  mainly takes place in the liver via
oxidation of 3-methoxy-4-hydroxyphenylglycol (MHPG). Twenty
percent of the peripheral MHPG derive from the brain and so it
is only to a small extent that we can exploit changes in urinary
VMA to map  out central changes in NE concentrations (Eisenhofer
et al., 2004). When interpreting the results of this study, one must
be aware of the possible interferences in measuring urinary neuro-
transmitter metabolites and the distinct sources and metabolism
pathways of both HVA and VMA  (Goldstein et al., 2003). However,
measurement of urinary metabolites is still the most convenient
assessment because it is non-invasive and does not pose any risk
to individuals.
Conclusion
In summary, this study examined neurotoxic effects of occupa-
tional exposure to PCBs on urinary metabolites of DA  and NE. The
results give preliminary evidence for inverse effects of PCBs on neu-
rotransmitter metabolites in urine from highly exposed individuals.
Longitudinally, PCB exposure was  associated with a decreased HVA
level over time. A further analysis of the several types of PCBs
was associated with different long-term effects on the metabolites,
providing hints to complex mixed exposure effects that should be
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onsidered in further analyses. Our ﬁndings, which should be repli-
ated, support the outcome of a previous study which reported
CB-induced effects on DAT in occupationally exposed women
Seegal et al., 2010) and provide a basis for the documenting under-
ying pathomechanisms in both women and men.
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